News & Insights

Client Alert: CTA Update – Texas Case – Appeal Filed; FinCEN Position 12/09/24  |  Alerts Morse Serves as Counsel to The Bridge in Acquisition of Data Consulting Firm 12/06/24  |  Deal News Attorney Taimoor Choudhry Joins Morse 12/05/24  |  Announcements Corporate Transparency Act – FAQs 12/04/24  |  Articles Section 83(b) Elections – Navigating Fertile Ground for Bad Results 10/28/24  |  Articles What’s Market: Indemnification Caps and Baskets in M&A Transactions 9/25/24  |  Articles WEBINAR: 30 Mins: Navigating the Corporate Transparency Act Event Date
September 12, 2024 12:30 pm Morse Serves as Counsel in Myeloma Investment Fund’s Investment in Envisagenics 8/02/24  |  Announcements Five Steps to Preparing for Your Venture Capital Financing 5/20/24  |  Articles Preparing for Investment – How Organized are your Corporate Documents? 5/15/24  |  Articles A Few Things to Know About Founders Preferred Stock 5/03/24  |  Articles Building Resilient Biotechnology Research in the Shadow of The Biosecure Act Event Date
March 28, 2024 7:00 pm Three Things to Consider in a Corporate Venture Capital Investment 3/06/24  |  Articles VC Deals: Morse Ranked in 18 Categories in 2023 PitchBook League Tables 3/05/24  |  Announcements 2023 VC Deals 2/21/24  |  Announcements 2019-2023 M&A Deals 2/21/24  |  Announcements Morse Welcomes Corporate Counsel Daniel E. Wilcox 2/13/24  |  Announcements Morse Announces 2024 Attorney Elevations 1/02/24  |  Announcements Celebrating the Career of Carl Barnes: A Retirement Announcement 1/01/24  |  Announcements Client Alert: Product Pricing May Be Relevant When Federal Agencies Consider Exercising March-in Rights 12/19/23  |  Alerts
Show More